JNJ · News · 20260814N

Regulatory Approval Milestones

JOHNSON & JOHNSON · 2026-08-14 · Importance 41 · Surprise 60 · In source text

Third-party reporting says Johnson & Johnson’s Ottava surgical robotics system received FDA authorization in the United States. The authorization enables Ottava to compete directly with Intuitive Surgical’s da Vinci systems in the U.S. surgical robotics market. The report highlights Ottava’s space-saving design and integration with Johnson & Johnson’s existing surgical tools as potential differentiators affecting future placement and procedure volumes.

Key facts

Impact estimates

metricdirectionstageexpectedbasis
revenuepositiveprobableJohnson & Johnson's Ottava surgical system received FDA authorization.